Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Ten Haaf

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|October 6, 2014
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancersNanda Horeweg, Ernst Th Scholten, Pim A de Jong, et al.
The Lancet. Oncology|June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trialJoan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
Cancer|March 1, 2014
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trialsRafael Meza, Kevin ten Haaf, Chung Yin Kong, et al.
The Lancet. Oncology|October 6, 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screeningNanda Horeweg, Joost van Rosmalen, Marjolein A Heuvelmans, et al.
Annals of Internal Medicine|December 15, 2025
Eligibility and Prognostic Performance of Smoking Duration-Based Versus Pack-Year-Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic GroupsChloe C Su, Victoria Y Ding, Kevin Ten Haaf, et al.
Plos One|July 1, 2014
Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modelingPamela M McMahon, Rafael Meza, Sylvia K Plevritis, et al.
JAMA Oncology|October 26, 2023
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the USEunji Choi, Victoria Y Ding, Sophia J Luo, et al.
Annals of Internal Medicine|January 1, 2014
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceHarry J de Koning, Rafael Meza, Sylvia K Plevritis, et al.
The New England Journal of Medicine|January 30, 2020
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialHarry J de Koning, Carlijn M van der Aalst, Pim A de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2025
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screeningJames L Mulshine, Bruce Pyenson, Cheryl Healton, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|October 6, 2014
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancersNanda Horeweg, Ernst Th Scholten, Pim A de Jong, et al.
The Lancet. Oncology|June 11, 2016
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trialJoan E Walter, Marjolein A Heuvelmans, Pim A de Jong, et al.
Cancer|March 1, 2014
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trialsRafael Meza, Kevin ten Haaf, Chung Yin Kong, et al.
The Lancet. Oncology|October 6, 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screeningNanda Horeweg, Joost van Rosmalen, Marjolein A Heuvelmans, et al.
Annals of Internal Medicine|December 15, 2025
Eligibility and Prognostic Performance of Smoking Duration-Based Versus Pack-Year-Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic GroupsChloe C Su, Victoria Y Ding, Kevin Ten Haaf, et al.
Plos One|July 1, 2014
Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modelingPamela M McMahon, Rafael Meza, Sylvia K Plevritis, et al.
JAMA Oncology|October 26, 2023
Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the USEunji Choi, Victoria Y Ding, Sophia J Luo, et al.
Annals of Internal Medicine|January 1, 2014
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task ForceHarry J de Koning, Rafael Meza, Sylvia K Plevritis, et al.
The New England Journal of Medicine|January 30, 2020
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialHarry J de Koning, Carlijn M van der Aalst, Pim A de Jong, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2025
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screeningJames L Mulshine, Bruce Pyenson, Cheryl Healton, et al.
Pageof 8